347 related articles for article (PubMed ID: 20138809)
1. Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials.
Hopwood P; Haviland JS; Sumo G; Mills J; Bliss JM; Yarnold JR;
Lancet Oncol; 2010 Mar; 11(3):231-40. PubMed ID: 20138809
[TBL] [Abstract][Full Text] [Related]
2. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.
Haviland JS; Owen JR; Dewar JA; Agrawal RK; Barrett J; Barrett-Lee PJ; Dobbs HJ; Hopwood P; Lawton PA; Magee BJ; Mills J; Simmons S; Sydenham MA; Venables K; Bliss JM; Yarnold JR;
Lancet Oncol; 2013 Oct; 14(11):1086-1094. PubMed ID: 24055415
[TBL] [Abstract][Full Text] [Related]
3. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
[TBL] [Abstract][Full Text] [Related]
4. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.
; Bentzen SM; Agrawal RK; Aird EG; Barrett JM; Barrett-Lee PJ; Bliss JM; Brown J; Dewar JA; Dobbs HJ; Haviland JS; Hoskin PJ; Hopwood P; Lawton PA; Magee BJ; Mills J; Morgan DA; Owen JR; Simmons S; Sumo G; Sydenham MA; Venables K; Yarnold JR
Lancet Oncol; 2008 Apr; 9(4):331-41. PubMed ID: 18356109
[TBL] [Abstract][Full Text] [Related]
5. Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials.
Haviland JS; Mannino M; Griffin C; Porta N; Sydenham M; Bliss JM; Yarnold JR;
Radiother Oncol; 2018 Jan; 126(1):155-162. PubMed ID: 29153463
[TBL] [Abstract][Full Text] [Related]
6. One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
Brunt AM; Haviland JS; Wheatley DA; Sydenham MA; Bloomfield DJ; Chan C; Cleator S; Coles CE; Donovan E; Fleming H; Glynn D; Goodman A; Griffin S; Hopwood P; Kirby AM; Kirwan CC; Nabi Z; Patel J; Sawyer E; Somaiah N; Syndikus I; Venables K; Yarnold JR; Bliss JM;
Health Technol Assess; 2023 Nov; 27(25):1-176. PubMed ID: 37991196
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.
Murray Brunt A; Haviland JS; Wheatley DA; Sydenham MA; Alhasso A; Bloomfield DJ; Chan C; Churn M; Cleator S; Coles CE; Goodman A; Harnett A; Hopwood P; Kirby AM; Kirwan CC; Morris C; Nabi Z; Sawyer E; Somaiah N; Stones L; Syndikus I; Bliss JM; Yarnold JR;
Lancet; 2020 May; 395(10237):1613-1626. PubMed ID: 32580883
[TBL] [Abstract][Full Text] [Related]
8. Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial.
Meattini I; Saieva C; Miccinesi G; Desideri I; Francolini G; Scotti V; Marrazzo L; Pallotta S; Meacci F; Muntoni C; Bendinelli B; Sanchez LJ; Bernini M; Orzalesi L; Nori J; Bianchi S; Livi L
Eur J Cancer; 2017 May; 76():17-26. PubMed ID: 28262584
[TBL] [Abstract][Full Text] [Related]
9. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.
; Bentzen SM; Agrawal RK; Aird EG; Barrett JM; Barrett-Lee PJ; Bentzen SM; Bliss JM; Brown J; Dewar JA; Dobbs HJ; Haviland JS; Hoskin PJ; Hopwood P; Lawton PA; Magee BJ; Mills J; Morgan DA; Owen JR; Simmons S; Sumo G; Sydenham MA; Venables K; Yarnold JR
Lancet; 2008 Mar; 371(9618):1098-107. PubMed ID: 18355913
[TBL] [Abstract][Full Text] [Related]
10. Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial.
Velikova G; Williams LJ; Willis S; Dixon JM; Loncaster J; Hatton M; Clarke J; Kunkler IH; Russell NS;
Lancet Oncol; 2018 Nov; 19(11):1516-1529. PubMed ID: 30337220
[TBL] [Abstract][Full Text] [Related]
11. HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial.
Yadav BS; Dahiya D; Kannan P; Goyal S; Laroiya I; Irrinki S; Singh NR; Sharma R
Trials; 2024 Jan; 25(1):21. PubMed ID: 38167339
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
Wilkins A; Mossop H; Syndikus I; Khoo V; Bloomfield D; Parker C; Logue J; Scrase C; Patterson H; Birtle A; Staffurth J; Malik Z; Panades M; Eswar C; Graham J; Russell M; Kirkbride P; O'Sullivan JM; Gao A; Cruickshank C; Griffin C; Dearnaley D; Hall E
Lancet Oncol; 2015 Dec; 16(16):1605-16. PubMed ID: 26522334
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy.
Versmessen H; Vinh-Hung V; Van Parijs H; Miedema G; Voordeckers M; Adriaenssens N; Storme G; De Ridder M
BMC Cancer; 2012 Oct; 12():495. PubMed ID: 23098579
[TBL] [Abstract][Full Text] [Related]
14. Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.
Coles CE; Griffin CL; Kirby AM; Titley J; Agrawal RK; Alhasso A; Bhattacharya IS; Brunt AM; Ciurlionis L; Chan C; Donovan EM; Emson MA; Harnett AN; Haviland JS; Hopwood P; Jefford ML; Kaggwa R; Sawyer EJ; Syndikus I; Tsang YM; Wheatley DA; Wilcox M; Yarnold JR; Bliss JM;
Lancet; 2017 Sep; 390(10099):1048-1060. PubMed ID: 28779963
[TBL] [Abstract][Full Text] [Related]
15. Patient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled Trial.
Bhattacharya IS; Haviland JS; Kirby AM; Kirwan CC; Hopwood P; Yarnold JR; Bliss JM; Coles CE;
J Clin Oncol; 2019 Feb; 37(4):305-317. PubMed ID: 30532984
[TBL] [Abstract][Full Text] [Related]
16. The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial).
Hopwood P; Haviland J; Mills J; Sumo G; M Bliss J;
Breast; 2007 Jun; 16(3):241-51. PubMed ID: 17236771
[TBL] [Abstract][Full Text] [Related]
17. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.
Whelan TJ; Lada BM; Laukkanen E; Perera FE; Shelley WE; Levine MN
Cancer Prev Control; 1997 Aug; 1(3):228-40. PubMed ID: 9765748
[TBL] [Abstract][Full Text] [Related]
18. A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial.
Prescott RJ; Kunkler IH; Williams LJ; King CC; Jack W; van der Pol M; Goh TT; Lindley R; Cairns J
Health Technol Assess; 2007 Aug; 11(31):1-149, iii-iv. PubMed ID: 17669280
[TBL] [Abstract][Full Text] [Related]
19. Prolongation of overall treatment time as a cause of treatment failure in early breast cancer: An analysis of the UK START (Standardisation of Breast Radiotherapy) trials of radiotherapy fractionation.
Haviland JS; Bentzen SM; Bliss JM; Yarnold JR;
Radiother Oncol; 2016 Dec; 121(3):420-423. PubMed ID: 27666929
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial.
Offersen BV; Alsner J; Nielsen HM; Jakobsen EH; Nielsen MH; Krause M; Stenbygaard L; Mjaaland I; Schreiber A; Kasti UM; Overgaard J;
J Clin Oncol; 2020 Nov; 38(31):3615-3625. PubMed ID: 32910709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]